Evidence map›Paper›PMID 25699289›Full record

ArticleNext generation, sequencing & applications

Accuracy of Next Generation Sequencing Platforms.

Edward J Fox, Kate S Reid-Bayliss, Mary J Emond, Lawrence A Loeb

Abstract read
In one paragraph

Article in Next generation, sequencing & applications. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed.

  1. Article
  2. Establishment of CRISPR/Cas9 Genome Editing inJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Comparison ofMicrobiology spectrum · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Edward J FoxDepartments of Pathology and Biochemistry, University of Washington, USA.
Kate S Reid-BaylissDepartment of Biostatistics, University of Washington, USA.
Mary J Emond
Lawrence A Loeb

Funding

University of Washington Medical Scientist Training Program: MD/PhDT32GM007266 · NIGMS · UNIVERSITY OF WASHINGTON · PI HORWITZ, MARSHALL S. · 1985 to 2023
$30.4M
SPECIFICITY OF OXYGEN DNA DAMAGE AND MUTAGENESISP01AG001751 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 1985 to 2021
$29.6M
University of Washington Nathan Shock Center of Excellence in the Basic Biology of AgingP30AG013280 · NIA · UNIVERSITY OF WASHINGTON · PI Su-In Lee · 1995 to 2026
$27.1M
Tumor mutation signaturesP01CA077852 · NCI · UNIVERSITY OF WASHINGTON · PI MONNAT, RAYMOND J · 1999 to 2019
$26.0M
GENETIC APPROACHES TO AGING RESEARCHT32AG000057 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 1985 to 2019
$14.2M
Fidelity of DNA SynthesisR01CA102029 · NCI · UNIVERSITY OF WASHINGTON · PI LOEB, LAWRENCE A · 2003 to 2012
$3.3M
Clonally Expanded Mutations Identify Cancer Precursors in Chronic InflammationR01CA160674 · NCI · UNIVERSITY OF WASHINGTON · PI BRENTNALL, TERESA A, LOEB, LAWRENCE A · 2012 to 2016
$2.8M
Mutator Phenotype in Human CancersR01CA115802 · NCI · UNIVERSITY OF WASHINGTON · PI LOEB, LAWRENCE A · 2007 to 2011
$1.5M
Validation and Advanced Development of Duplex SequencingR33CA181771 · NCI · UNIVERSITY OF WASHINGTON · PI LOEB, LAWRENCE A · 2014 to 2016
$1.1M
NCI NIH HHS P01 CA077852NCI NIH HHS R01 CA102029NCI NIH HHS R01 CA115802NCI NIH HHS R01 CA160674NCI NIH HHS R33 CA181771NIA NIH HHS P01 AG001751NIA NIH HHS P30 AG013280NIA NIH HHS T32 AG000057NIGMS NIH HHS T32 GM007266
6 · The paper itself

Abstract

Next-generation DNA sequencing has revolutionized genomic studies and is driving the implementation of precision diagnostics. The ability of these technologies to disentangle sequence heterogeneity, however, is limited by their relatively high error rates. A Several single molecule barcoding strategies have been propose to reduce the overall error frequency. A Duplex Sequencing additionally exploits the fact that DNA is double-strand, with one strand reciprocally encoding the sequence information of its complement, and can eliminate nearly all sequencing errors by comparing the sequence of individually tagged amplicons derived from one strand of DNA with that of its complementary strand. This method reduces errors to fewer than one per ten million nucleotides sequenced.

Indexed as

AccuracyDuplex sequencingNext-generation DNA sequencingPrecision medicine

Identifiers

PMID25699289
PMCPMC4331009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.